Monogram Technologies, headquartered in Austin, Texas, is an AI-driven medical device company developing an autonomous robotic system for patient-customized joint replacements with high precision. Their platform integrates 3D-printed, patient-matched knee implants with computer vision, machine learning, and robotic bone cutting to optimize surgical planning and execution while reducing time and variability. The company recently received FDA clearance for its mBôs total knee arthroplasty system, which is currently undergoing clinical trials, and is set to be acquired by Zimmer Biomet.